Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Anja B Drebes"'
Autor:
Michael Makris, Susie Shapiro, Claire Lentaigne, Sarah Lewis, Zain Odho, Caroline Allan, Lara N. Roberts, Mari Frances Kilner, Tina Dutt, Deepa R. J. Arachchillage, Roderick Oakes, Philip Mounter, Zara Margarite Sayar, Priyanka Raheja, Gillian C. Lowe, Alison Delaney, Anja B Drebes, Alexander Langridge, Christina Crossette-Thambiah, Richard Szydlo, David Sutton, Nini Aung, Raza Alikhan, Renu Riat, Tamara Everington, Sarah Essex, Indika Rajakaruna, Phillip L R Nicolson, Ceri Lynch, Michael Laffan
Publikováno v:
British journal of haematologyReferences. 196(1)
Coagulation dysfunction and thrombosis are major complications in patients with coronavirus disease 2019 (COVID-19). Patients on oral anticoagulants (OAC) prior to diagnosis of COVID-19 may therefore have better outcomes. In this multicentre observat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adaf5a12d71604dfecf3ecd9eeb6a1d7
https://pubmed.ncbi.nlm.nih.gov/34500500
https://pubmed.ncbi.nlm.nih.gov/34500500
Autor:
Neil Davies, Anja B Drebes
Publikováno v:
Current Pharmaceutical Design. 24:4525-4533
In recent years, there has been an increasing interest in endovascular iliofemoral vein stenting to prevent/ alleviate symptoms related to proximal venous outflow obstruction. Maintaining long-term stent patency is one of the main challenges, and ris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a0bb1bfb2098d94655c44be05bdc9e4
https://doi.org/10.2174/1381612825666181226151114
https://doi.org/10.2174/1381612825666181226151114
Autor:
L. Roberts, Christina Crossette-Thambiah, Indika Rajakaruna, Sarah Lewis, Tamara Everington, Ceri Lynch, D. Sutton, P. Raheja, C. Allan, P. Mounter, Deepa R. J. Arachchillage, Laffan, Renu Riat, R. Oakes, S. Essex, Gillian C. Lowe, Z. Odho, Mari Frances Kilner, A. Langridge, N. Aung, A. Delaney, Anja B Drebes, Susie Shapiro, Richard Szydlo, Raza Alikhan, Phillip L R Nicolson, Tina Dutt, M. Makris, Z. Sayer, C. Lentaigne
Publikováno v:
SSRN Electronic Journal.
Coagulation dysfunction and thrombosis are major complications in patients with coronavirus disease-19 (COVID-19). Patients on oral anticoagulants prior to diagnosis of COVID-19 may therefore have better outcomes. We aimed: To first document the freq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5e85ef4ea2d1cb514eed10946c979a5
https://doi.org/10.2139/ssrn.3866562
https://doi.org/10.2139/ssrn.3866562
Autor:
James Lenton, Richard Tippett, Stephen Black, Previn Diwakar, Andrew Shawyer, Kim Fortin, Robert G. Jones, Alun H. Davies, Andrew P. Willis, Neil Davies, Prakash Saha, Anja B Drebes, N Burfitt, James Scurr, Chung S. Lim, Abdulrahman Alvi, H M Moore, Julian Hague, Sally Vrebac, Tanya Kearney, Deborah Low, Usman Shaikh, Peter Schnatterbeck, Robert S. Ward, Christopher J. Hammond, Karen Breen, Toby Richards, Shaun Quigley, David Beckett, James Metcalfe, Christopher Watts, Nick Woodward, Liz Haslam, Shirish Prabhudesai, Bhim J. Odedra, Lakshmi Ratnam, Andrew Wigham, Simon Coles, Manjit S. Gohel, Shoaib Shaikh, Sara J. Baker, Eldon D. Lehmann
Publikováno v:
International Angiology. 39
The aim of this manuscript was to establish a consensus for the management of acute and chronic venous obstruction among specialists in the UK. Specialist physicians representing vascular surgery, interventional radiology and hematology were invited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c9eb0da329b266aa08ca82dd59ebd0f
https://doi.org/10.23736/s0392-9590.19.04278-0
https://doi.org/10.23736/s0392-9590.19.04278-0
Publikováno v:
Therapeutic Advances in Hematology. 8:263-272
Acquired haemophilia A (AHA) is a rare, serious bleeding disorder most often encountered in elderly patients. The mainstay of haemostatic management is with bypassing agents (BPAs) including recombinant activated factor VII (rFVIIa) and activated pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bb7e0a43e292b006f4979458797276a
https://doi.org/10.1177/2040620717720861
https://doi.org/10.1177/2040620717720861
Publikováno v:
Current pharmaceutical design. 22(29)
Background Acetylsalicylic acid and clopidogrel are two antiplatelet agents currently used in the therapy of peripheral arterial disease. Cilostazol also inhibits platelet aggegration. These agents present limitations that novel antiplatelet agents m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e15af80ded7f6e4db9d02e7ecc4a029
https://pubmed.ncbi.nlm.nih.gov/27281329
https://pubmed.ncbi.nlm.nih.gov/27281329
Publikováno v:
Disorders of Thrombosis and Hemostasis in Pregnancy ISBN: 9783319151199
Management of anticoagulant or antiplatelet therapy in pregnant women is challenging because of a paucity of data on its efficacy and safety during pregnancy. Current recommendations are based largely on extrapolation of data from non-pregnant patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9983519425a8b7d3f14df73cda98542c
https://doi.org/10.1007/978-3-319-15120-5_2
https://doi.org/10.1007/978-3-319-15120-5_2
Publikováno v:
Lancet (London, England). 382(9907)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5b7f3eb4d4f36d27e07dcad6ae5e521
https://pubmed.ncbi.nlm.nih.gov/24290590
https://pubmed.ncbi.nlm.nih.gov/24290590
Publikováno v:
Blood. 128:5018-5018
Background: The direct, oral, factor Xa inhibitor, rivaroxaban, is increasingly used to provide effective anticoagulation in atrial fibrillation and venous thromboembolism. Whilst rivaroxaban does not require therapeutic monitoring there are situatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::611abedb1d9e63816b07e7320c461393
https://doi.org/10.1182/blood.v128.22.5018.5018
https://doi.org/10.1182/blood.v128.22.5018.5018
Publikováno v:
Blood. 124:1512-1512
Background Acquired haemophilia A (AHA) is a rare and potentially fatal bleeding disorder characterised by the development of autoantibodies directed against factor VIII. The optimal treatment for AHA remains uncertain and there is a paucity of publi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9777621c779a9f2b696563e16b7d81fd
https://doi.org/10.1182/blood.v124.21.1512.1512
https://doi.org/10.1182/blood.v124.21.1512.1512